D. Babcock

A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network.

Jeffrey J. Annon, W. Ling, L. Amass, 2005, Addiction.

The effect of psychological stress, training load, and energy availability on the prevalence of athletic amenorrhea in NCAA Division I and Division III distance runners

D. Babcock, 2012 .

Internet-delivered treatment for substance abuse: a multisite randomized controlled trial.

Daniel Polsky, U. Ghitza, E. Nunes, 2014, The American journal of psychiatry.

The Use of Technology in Participant Tracking and Study Retention: Lessons Learned from A Clinical Trials Network Study

D. Babcock, M. Stitzer, G. Miele, 2015, Substance abuse.

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.

Jeffrey J. Annon, Thomas E. Freese, W. Ling, 2004, The American journal on addictions.

Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.

W. Ling, L. Amass, J. Annon, 2009, Drug and alcohol dependence.

Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users.

Sarah J. Erickson, D. Babcock, T. Winhusen, 2008, Journal of substance abuse treatment.

Internet-delivered treatment for substance abuse: a multisite randomized controlled trial.

Udi E. Ghitza, E. Nunes, D. Babcock, 2014, The American journal of psychiatry.

Improving Treatment for Opioid Dependence: A Perspective From the Ohio Valley Node of the NIDA Clinical Trials Network

D. Babcock, Gregory S. Brigham, T. Winhusen, 2014, Progress in community health partnerships : research, education, and action.

Determining the Initiation of Opiate Misuse Resulting in Opioid Use Disorder in Pregnant Women

D. Babcock, D. Haas, Abigail R. Vinson, 2018, Journal of psychoactive drugs.